CTIS.eu › Cities › France › Paris
Paris
France
2,286 total trials
1,022 recruiting
Filter these 2,286 trials by phase, condition, sponsor and more.
Open in Search →
2025-521792-31-01
5
2026-04-07
Homozygous Familial Hypercholesterolemia (HoFH)
2025-521521-33-00
10
2026-04-02
Kidney transplant rejection
2025-522191-86-00
5
2026-04-02
Focal segmental glomerulosclerosis
2025-522279-27-00
5
2026-04-02
Newly Diagnosed AML with an NPM1 mutation
2024-519578-38-00
10
2026-03-30
Classic congenital adrenal hyperplasia
2025-521142-22-00
5
2026-03-27
Hereditary Angioedema
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
2025-523160-20-00
1
2026-03-23
Advanced solid tumors
2025-522892-27-00
4
2026-03-21
Bronchiectasis
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
2024-519555-28-00
5
2026-03-18
Dravet syndrome
2024-519537-29-00
1
2026-03-13
Acute Myeloid Leukemia and Myelodysplastic Syndrome
2025-520805-10-00
5
2026-03-12
Chronic inflammatory demyelinating polyneuropathy (CIDP)
2024-516476-15-00
9
2026-03-04
Advanced gastrointestinal stromal tumor (GIST)
2024-519579-24-00
5
2026-02-26
Classic Congenital Adrenal Hyperplasia
2025-522033-64-00
1
2026-02-26
Myelofibrosis
2025-522553-19-00
10
2026-02-25
Symptomatic genetic and familial dilated cardiomyopathy.
2024-520353-21-00
3
2026-02-24
Myeloproliferative Neoplasms
2024-520098-12-00
4
2026-02-16
Cutaneous Lupus Erythematosus
2024-516216-16-00
5
2026-02-13
Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lo
2024-520200-26-00
4
2026-02-13
Inherited anemias
2024-519068-42-00
10
2026-02-12
Heterozygous Familial Hypercholesterolemia in pediatric patients
2025-522170-36-00
5
2026-02-03
Diabetes Mellitus, Type 1
Showing 265–288 of 2,286 trials